Recent research from the US has taken a closer look at the use of high‑risk medicines in children’s dental care. The study focused on pain medicines and sedatives prescribed around dental visits for patients under 18 years of age. Although these prescriptions were not very common overall, the authors found that when opioids and similar drugs were used, they were often followed by problems. The work adds to ongoing concerns about how children’s pain is managed after dental procedures and how strictly current recommendations are followed.

The researchers used several years of insurance claims data to identify dental visits for children and to see which of these visits were linked to prescriptions for opioids or benzodiazepines. These drugs can increase the risk of breathing problems, emergency treatment, hospitalisation and even longer‑term harm if they are not used carefully. The analysis showed that only a small share of dental visits involved such medicines. However, among the children who did receive these drugs, the need for follow‑up care—such as emergency department visits or short‑term hospital stays—was noticeably higher. In addition, a smaller group of patients continued to use opioids beyond the first days after the procedure, raising questions about early exposure and the possibility of developing longer‑term dependence.

The study also pointed to which children and which care settings seemed to be at higher risk. Younger children who were given opioids were particularly vulnerable to medicine‑related harms. Children with complex chronic medical conditions were another high‑risk group, reflecting how medically fragile patients can be more easily affected by powerful medicines in the dental chair. Differences were seen between routine outpatient clinics and more structured hospital or specialist settings. In environments with clearer protocols, closer monitoring and more frequent use of non‑opioid, multimodal pain control, adverse outcomes appeared to be less common.

For dental professionals, the findings are a reminder that safer prescribing in paediatric dentistry depends on careful, guideline‑based decisions. Many procedures that are expected to cause only limited or mild pain can be managed effectively with combinations of common non‑opioid pain relievers, rather than with opioids. Before choosing high‑risk medicines, clinicians should have access to an accurate medical history and should consider the child’s age, general health and other treatments. Strengthening training on paediatric pain management and using standardised, non‑opioid‑first approaches may help reduce preventable harm and support more comfortable and safer dental experiences for young patients.